Ecovyst Reports Third Quarter 2026 Results and Raises 2026 Outlook
Ecovyst Inc. (NYSE: ECVT) ("Ecovyst" or the "Company"), a leading provider of regenerated sulfuric acid, virgin sulfuric acid, and sulfur dioxide and…
Category
319 releases
Ecovyst Inc. (NYSE: ECVT) ("Ecovyst" or the "Company"), a leading provider of regenerated sulfuric acid, virgin sulfuric acid, and sulfur dioxide and…
The acquisition combines Asper's agentic AI capabilities with Pricing One's deep RGM expertise, 650+ proven commercial execution plans and…
GomSpace delivers revenue growth with a 14% EBITDA margin in Q3 and sets 2030 financial targets of SEK 1.6 billion in revenue and an EBITDA margin…
GomSpace has set medium term financial targets to reach SEK 1.6 billion in annual revenue by 2030 and achieve an EBITDA margin above 20% over the…
- Cigarette business achieves record quarterly revenue and operating profit, with operating margin reaching 32.6% - Annual dividend planned at KRW…
Acquisition adds three established communications agencies and a proprietary AI platform, placing AVENIR GLOBAL among the world's 15 largest…
The strategic investment from two global institutional-grade players, alongside follow-on support from Token Bay Capital, joins a Galaxy-led round…
Bluevua Honored for Excellence in Technology, Product Innovation, and Business Growth LOS ANGELES, Nov. 5, 2026 — Bluevua®, a leader in countertop…
Continued Sales Momentum and Cost Discipline Highlight 3Q Progress NOVI, Mich., Nov. 4, 2026 — Stoneridge, Inc. (NYSE: SRI) today announced financial…
Oral, highly selective and potent VAV1 molecular glue degrader designed to deliver a differentiated clinical profile across a broad range of…
Bruce Broussard to Succeed Chip Bergh as Chair of the Board
Achieves 30% Revenue Growth Year-Over-Year
Youlife Group Inc. ("Youlife" or the "Company") (NASDAQ: YOUL), a leading blue-collar lifetime service provider in China, today announced that it has…
Company raises full-year revenue and earnings outlook again and increases full-year cash flow expectations
Revenue growth of 27% driven by strong performance in molecular profiling services, including approximately 61,500 clinical cases, consisting of over…